Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions

Vascular Pharmacology

Volumn 51, Issue 5-6, 2009, Pages 331-336

  Bazan, Hernan A ^a,b   Lu, Yan ^c   Thoppil, Deepu ^b   Fitzgerald, Tamara N ^d,e   Hong, Song ^c   Dardik, Alan ^d,e  

^a Section of Vascular Surgery   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Carotid; Inflammation; Instability; Omega 3; Plaque

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTERNAL CAROTID ARTERY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAROTID ARTERY DISEASES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 70449119954     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.08.003     Document Type: Article

References (20)

1. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging. 8 (2004) 163-174
2. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 83 (2006) 1505S-1519S
3. Dona M., Fredman G., Schwab J.M., Chiang N., Arita M., Goodarzi A., et al. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 112 (2008) 848-855
4. Ebbesson S.O., Roman M.J., Devereux R.B., Kaufman D., Fabsitz R.R., Maccluer J.W., et al. Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Coronary Artery Disease in Alaska Natives study. Atherosclerosis. 199 (2008) 346-353
5. Harris W.S. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr. 87 (2008) 1997S-2002S
6. Jacobson T.A. Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol. 98 (2006) 61i-70i
7. Kang J.X., and Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr. 71 (2000) 202S-207S
8. Kris-Etherton P.M., Harris W.S., Appel, and L.J. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 23 (2003) 151-152
9. Kromhout D., Bosschieter E.B., and de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 312 (1985) 1205-1209
10. Leaf A., Albert C.M., Josephson M., Steinhaus D., Kluger J., Kang J.X., et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 112 (2005) 2762-2768
11. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., and Tracy R.P. Siscovick DS. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 77 (2003) 319-325
12. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation. 105 (2002) 1135-1143
13. Miller D.T., Ridker P.M., Libby P., and Kwiatkowski D.J. Atherosclerosis: the path from genomics to therapeutics. J Am Coll Cardiol. 49 (2007) 1589-1599
14. Mita T., Watada H., Ogihara T., Nomiyama T., Ogawa O., Kinoshita J., et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis. 191 (2007) 162-167
15. Morgan D.R., Dixon L.J., Hanratty C.G., El-Sherbeeny N., Hamilton P.B., McGrath L.T., et al. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol. 97 (2006) 547-551
16. Schiano V., Laurenzano E., Brevetti G., De Maio J.I., Lanero S., Scopacasa F., et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr. 27 (2008) 241-247
17. Tanaka K., Ishikawa Y., Yokoyama M., Origasa H., Matsuzaki M., Saito Y., et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 39 (2008) 2052-2058
18. Tavani A., Pelucchi C., Negri E., Bertuzzi M., and La Vecchia C. n-3 polyunsaturated fatty acids, fish, and nonfatal acute myocardial infarction. Circulation. 104 (2001) 2269-2272
19. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 361 (2003) 477-485
20. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 369 (2007) 1090-1098